Compare
OptimizeRx Corp vs FiscalNote Holdings, Inc. vs DHI Group, Inc. vs Research Solutions, Inc.
| Latest fiscal year | OptimizeRx Corp OPRX | FiscalNote Holdings, Inc. NOTE | DHI Group, Inc. DHX | Research Solutions, Inc. RSSS |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2026-06-30 |
| Revenue | $109.43M | $95.41M | $127.83M | $48.31M |
| Revenue growth (YoY) | +18.8% | -20.7% | -9.9% | -1.5% |
| Gross margin | 67.3% | n/a | 84.7% (computed) | 51.9% |
| Operating margin | 10.7% | -51.9% | -8.9% | 7.4% |
| Net margin | 4.7% | -68.4% | -10.6% | 5.8% |
| Net income | $5.13M | -$65.25M | -$13.51M | $2.82M |
| EPS (Diluted) | $0.27 | -$4.65 | -$0.30 | $0.09 |
| Operating cash flow | $18.71M | -$11.44M | $21.10M | $5.27M |
| Free cash flow | $18.66M | -$18.65M | $13.79M | $5.23M |
| Cash & equivalents | $23.36M | $24.32M | $2.91M | $12.63M |
| Total assets | $176.92M | $255.14M | $188.24M | $45.66M |
| Total liabilities | $48.62M | $193.19M | $93.74M | $24.96M |
| Shareholders' equity | $128.29M | $61.95M | $94.51M | $20.71M |
| Return on year-end equity | 4.0% | -105.3% | -14.3% | 13.6% |
| Shares outstanding | 18.76M | n/a | 44.46M | 33.51M |
Revenue, most recent five fiscal years
| Fiscal year | OptimizeRx Corp | FiscalNote Holdings, Inc. | DHI Group, Inc. | Research Solutions, Inc. |
|---|---|---|---|---|
| Latest | $109.43M Ended 2025-12-31 | $95.41M Ended 2025-12-31 | $127.83M Ended 2025-12-31 | $48.31M Ended 2026-06-30 |
| 1 year earlier | $92.13M Ended 2024-12-31 | $120.27M Ended 2024-12-31 | $141.93M Ended 2024-12-31 | $49.06M Ended 2025-06-30 |
| 2 years earlier | $71.52M Ended 2023-12-31 | $132.65M Ended 2023-12-31 | $151.88M Ended 2023-12-31 | $44.62M Ended 2024-06-30 |
| 3 years earlier | $62.45M Ended 2022-12-31 | $113.77M Ended 2022-12-31 | $149.68M Ended 2022-12-31 | $37.70M Ended 2023-06-30 |
| 4 years earlier | $61.29M Ended 2021-12-31 | $82.91M Ended 2021-12-31 | $119.90M Ended 2021-12-31 | $32.93M Ended 2022-06-30 |